Lee, J.; Sung, P.S.; Yang, H.; Lee, S.K.; Nam, H.C.; Yoo, S.H.; Lee, H.L.; Kim, H.Y.; Lee, S.W.; Kwon, J.H.;
et al. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. J. Clin. Med. 2020, 9, 4121.
https://doi.org/10.3390/jcm9124121
AMA Style
Lee J, Sung PS, Yang H, Lee SK, Nam HC, Yoo SH, Lee HL, Kim HY, Lee SW, Kwon JH,
et al. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. Journal of Clinical Medicine. 2020; 9(12):4121.
https://doi.org/10.3390/jcm9124121
Chicago/Turabian Style
Lee, Jaejun, Pil Soo Sung, Hyun Yang, Soon Kyu Lee, Hee Chul Nam, Sun Hong Yoo, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Jung Hyun Kwon,
and et al. 2020. "A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC" Journal of Clinical Medicine 9, no. 12: 4121.
https://doi.org/10.3390/jcm9124121
APA Style
Lee, J., Sung, P. S., Yang, H., Lee, S. K., Nam, H. C., Yoo, S. H., Lee, H. L., Kim, H. Y., Lee, S. W., Kwon, J. H., Jang, J. W., Kim, C. W., Nam, S. W., Bae, S. H., Choi, J. Y., & Yoon, S. K.
(2020). A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. Journal of Clinical Medicine, 9(12), 4121.
https://doi.org/10.3390/jcm9124121